Tokyo - Delayed Quote • JPY Delta-Fly Pharma, Inc. (4598.T) Follow Add holdings 647.00 +44.00 +(7.30%) At close: May 30 at 3:30:00 PM GMT+9 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure Undo Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 4598.T 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 4598.T View More All News Press Releases SEC Filings Delta-Fly Pharma, Inc.: Progress of Development Status of the Combination Study of DFP-10917 with Venetoclax Delta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 with Venetoclax Delta-Fly Pharma Inc.: Update for Development Status of DFP-17729 Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323 Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927 Delta-Fly Pharma Inc.: Phase I/II Study of DFP-10917 and Venetoclax in AML Patients Begins with Promising Initial Data Delta-Fly Pharma Inc.: Phase I/II Combo-study of DFP-10917 with Venetoclax in Patients with AML Initiates Enrollment of Patients Delta-Fly Pharma Inc.: Notice of initiation of patients enrollment in Phase III Pivotal comparative clinical trial of DFP-14323